A citation-based method for searching scientific literature

Maher Albitar, Hong Zhang, Andre Goy, Zijun Y Xu-Monette, Govind Bhagat, Carlo Visco, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D Hsi, Fredrick B Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés J M Ferreri, Michael B Møller, Benjamin M Parsons, J Han van Krieken, Miguel A Piris, Jane N Winter, Yong Li, Bing Xu, Ken H Young. Blood Cancer J 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma.
Wei Zhang, Li Yang, Yu' Qi Guan, Ke' Feng Shen, Mei' Lan Zhang, Hao' Dong Cai, Jia' Chen Wang, Ying Wang, Liang Huang, Yang Cao,[...]. BMC Cancer 2020
5
50

Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels.
Tobias Roider, Julian Seufert, Alexey Uvarovskii, Felix Frauhammer, Marie Bordas, Nima Abedpour, Marta Stolarczyk, Jan-Philipp Mallm, Sophie A Herbst, Peter-Martin Bruch,[...]. Nat Cell Biol 2020
46
50

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.
Hua You, Zijun Y Xu-Monette, Li Wei, Harry Nunns, Máté L Nagy, Govind Bhagat, Xiaosheng Fang, Feng Zhu, Carlo Visco, Alexandar Tzankov,[...]. Oncoimmunology 2021
3
50

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.
Stefano Monti, Kerry J Savage, Jeffery L Kutok, Friedrich Feuerhake, Paul Kurtin, Martin Mihm, Bingyan Wu, Laura Pasqualucci, Donna Neuberg, Ricardo C T Aguiar,[...]. Blood 2005
588
50

The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5.
Benoît Manfroi, Maria De Grandis, Jérôme Moreaux, Sébastien Tabruyn, Jean-François Mayol, Mélanie Quintero, Christian Righini, Nathalie Sturm, Michel Aurrand-Lions, Bertrand Huard. Blood Adv 2021
2
50

CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.
Colm Keane, Devinder Gill, Frank Vari, Donna Cross, Lynn Griffiths, Maher Gandhi. Am J Hematol 2013
60
50

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
561
50

Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
Moritz Ernst, Annika Oeser, Burcu Besiroglu, Julia Caro-Valenzuela, Mohamed Abd El Aziz, Ina Monsef, Peter Borchmann, Lise J Estcourt, Nicole Skoetz, Marius Goldkuhle. Cochrane Database Syst Rev 2021
5
50

Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.
M J Kersten, W Kraan, J Doorduijn, J Bromberg, K Lam, P M Kluin, B J van der Holt, M Spaargaren, S T Pals. Blood Cancer J 2014
7
50

Immune ageing at single-cell resolution.
Denis A Mogilenko, Irina Shchukina, Maxim N Artyomov. Nat Rev Immunol 2022
19
50

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
S Ciavarella, M C Vegliante, M Fabbri, S De Summa, F Melle, G Motta, V De Iuliis, G Opinto, A Enjuanes, S Rega,[...]. Ann Oncol 2018
64
50

Treatment of Diffuse Large B-Cell Lymphoma.
Kana Miyazaki. J Clin Exp Hematop 2016
43
50

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
Maysaa Abdulla, Andrei Alexsson, Christer Sundström, Claes Ladenvall, Larry Mansouri, Cecilia Lindskog, Mattias Berglund, Lucia Cavelier, Gunilla Enblad, Peter Hollander,[...]. Acta Oncol 2021
5
50

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Anas Younes, Laurie H Sehn, Peter Johnson, Pier Luigi Zinzani, Xiaonan Hong, Jun Zhu, Caterina Patti, David Belada, Olga Samoilova, Cheolwon Suh,[...]. J Clin Oncol 2019
226
50

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.
Anne M R Schrader, Patty M Jansen, Rein Willemze, Maarten H Vermeer, Anne-Marie Cleton-Jansen, Sebastiaan F Somers, Hendrik Veelken, Ronald van Eijk, Willem Kraan, Marie José Kersten,[...]. Blood 2018
44
50

Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry.
Dmitry R Bandura, Vladimir I Baranov, Olga I Ornatsky, Alexei Antonov, Robert Kinach, Xudong Lou, Serguei Pavlov, Sergey Vorobiev, John E Dick, Scott D Tanner. Anal Chem 2009
738
50

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.
Roni Shouval, Ana Alarcon Tomas, Joshua A Fein, Jessica R Flynn, Ettai Markovits, Shimrit Mayer, Aishat Olaide Afuye, Anna Alperovich, Theodora Anagnostou, Michal J Besser,[...]. J Clin Oncol 2022
12
50

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
M K Gandhi, T Hoang, S C Law, S Brosda, K O'Rourke, J W D Tobin, F Vari, V Murigneux, L Fink, J Gunawardana,[...]. Blood 2021
23
50

A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology.
Thomas Yssing Michaelsen, Julia Richter, Rasmus Froberg Brøndum, Wolfram Klapper, Hans Erik Johnsen, Mads Albertsen, Karen Dybkær, Martin Bøgsted. Blood Adv 2018
8
50

In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
Lukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, Pauline Biesemans, Julio Finalet Ferreiro, Koen Debackere, Peter Vandenberghe, Gregor Verhoef, Olivier Gheysens, Giorgio Cattoretti,[...]. Cancer Immunol Immunother 2020
19
50

Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.
Tianqi Xu, Jia Chai, Kaijing Wang, Qingge Jia, Yixiong Liu, Yingmei Wang, Junpeng Xu, Kangjie Yu, Danhui Zhao, Jing Ma,[...]. Front Oncol 2021
2
50

Dynamic chromatin regulatory landscape of human CAR T cell exhaustion.
David G Gennert, Rachel C Lynn, Jeff M Granja, Evan W Weber, Maxwell R Mumbach, Yang Zhao, Zhana Duren, Elena Sotillo, William J Greenleaf, Wing H Wong,[...]. Proc Natl Acad Sci U S A 2021
13
50

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Martine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, Katerina Bakunina, Rogier Mous, Pieternella J Lugtenburg, Daan Dierickx, Gustaaf W van Imhoff, Joost S P Vermaat, Erik A F Marijt,[...]. Haematologica 2020
15
50

Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencing.
Sally E Trabucco, Ethan S Sokol, Sophia L Maund, Jay A Moore, Garrett M Frampton, Lee A Albacker, Mikkel Z Oestergaard, Jeffrey Venstrom, Laurie H Sehn, Christopher R Bolen. Future Oncol 2021
1
100

Precision medicine in diffuse large B-cell lymphoma: hitting the target.
Joost S Vermaat, Steven T Pals, Anas Younes, Martin Dreyling, Massimo Federico, Igor Aurer, John Radford, Marie José Kersten. Haematologica 2015
18
50

Stromal gene signatures in large-B-cell lymphomas.
G Lenz, G Wright, S S Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, N Goldschmidt, J Iqbal,[...]. N Engl J Med 2008
50

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
50

The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.
Chloé B Steen, Bogdan A Luca, Mohammad S Esfahani, Armon Azizi, Brian J Sworder, Barzin Y Nabet, David M Kurtz, Chih Long Liu, Farnaz Khameneh, Ranjana H Advani,[...]. Cancer Cell 2021
29
50

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Daisuke Ennishi, Aixiang Jiang, Merrill Boyle, Brett Collinge, Bruno M Grande, Susana Ben-Neriah, Christopher Rushton, Jeffrey Tang, Nicole Thomas, Graham W Slack,[...]. J Clin Oncol 2019
153
50

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
Colm Keane, Frank Vari, Mark Hertzberg, Kim-Anh Lê Cao, Michael R Green, Erica Han, John F Seymour, Rodney J Hicks, Devinder Gill, Pauline Crooks,[...]. Lancet Haematol 2015
62
50

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Franck Morschhauser, Pierre Feugier, Ian W Flinn, Robin Gasiorowski, Richard Greil, Árpád Illés, Nathalie A Johnson, Jean-François Larouche, Pieternella J Lugtenburg, Caterina Patti,[...]. Blood 2021
35
50

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
50

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Stuart E Lacy, Sharon L Barrans, Philip A Beer, Daniel Painter, Alexandra G Smith, Eve Roman, Susanna L Cooke, Camilo Ruiz, Paul Glover, Suzan J L Van Hoppe,[...]. Blood 2020
129
50

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
Ash A Alizadeh, Andrew J Gentles, Alvaro J Alencar, Chih Long Liu, Holbrook E Kohrt, Roch Houot, Matthew J Goldstein, Shuchun Zhao, Yasodha Natkunam, Ranjana H Advani,[...]. Blood 2011
149
50

Whole transcriptome analysis with sequencing: methods, challenges and potential solutions.
Zhihua Jiang, Xiang Zhou, Rui Li, Jennifer J Michal, Shuwen Zhang, Michael V Dodson, Zhiwu Zhang, Richard M Harland. Cell Mol Life Sci 2015
69
50

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.
Georg Lenz, Inga Nagel, Reiner Siebert, Anna V Roschke, Warren Sanger, George W Wright, Sandeep S Dave, Bruce Tan, Hong Zhao, Andreas Rosenwald,[...]. J Exp Med 2007
143
50

Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
Anne M R Schrader, Ruben A L de Groen, Rein Willemze, Patty M Jansen, Koen D Quint, Tom van Wezel, Ronald van Eijk, Dina Ruano, Cornelis P Tensen, Esther Hauben,[...]. Virchows Arch 2022
6
50

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
Anja Mottok, George Wright, Andreas Rosenwald, German Ott, Colleen Ramsower, Elias Campo, Rita M Braziel, Jan Delabie, Dennis D Weisenburger, Joo Y Song,[...]. Blood 2018
39
50

Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.
Rong Shen, Peng-Peng Xu, Nan Wang, Hong-Mei Yi, Lei Dong, Di Fu, Jin-Yan Huang, Heng-Ye Huang, Anne Janin, Shu Cheng,[...]. Clin Transl Med 2020
21
50

Gene Expression Detection Assay for Cancer Clinical Use.
Shavira Narrandes, Wayne Xu. J Cancer 2018
43
50


Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma.
Jessica Rodrigues Plaça, Arjan Diepstra, Tjitske Los, Matías Mendeville, Annika Seitz, Pieternella J Lugtenburg, Josée Zijlstra, King Lam, Wilson Araújo da Silva, Bauke Ylstra,[...]. Cancers (Basel) 2022
1
100

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Joseph A Fraietta, Simon F Lacey, Elena J Orlando, Iulian Pruteanu-Malinici, Mercy Gohil, Stefan Lundh, Alina C Boesteanu, Yan Wang, Roddy S O'Connor, Wei-Ting Hwang,[...]. Nat Med 2018
718
50

Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma.
Niels W C J van de Donk, Maria Themeli, Saad Z Usmani. Blood Cancer Discov 2021
14
50

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.
Grzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, David W Scott, Qingyuan Zhang, Wojciech Jurczak, Muhit Özcan, Xiaonan Hong, Jun Zhu, Jie Jin,[...]. J Clin Oncol 2021
52
50

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Wyndham H Wilson, George W Wright, Da Wei Huang, Brendan Hodkinson, Sriram Balasubramanian, Yue Fan, Jessica Vermeulen, Martin Shreeve, Louis M Staudt. Cancer Cell 2021
39
50

Born to survive: how cancer cells resist CAR T cell therapy.
Jean Lemoine, Marco Ruella, Roch Houot. J Hematol Oncol 2021
15
50

Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
Christopher D Carey, Daniel Gusenleitner, Bjoern Chapuy, Alexandra E Kovach, Michael J Kluk, Heather H Sun, Rachel E Crossland, Chris M Bacon, Vikki Rand, Paola Dal Cin,[...]. J Mol Diagn 2015
20
50

The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Paul N Meyer, Kai Fu, Timothy Greiner, Lynette Smith, Jan Delabie, Randy Gascoyne, German Ott, Andreas Rosenwald, Rita Braziel, Elias Campo,[...]. Am J Clin Pathol 2011
54
50

Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures.
Nikita Kotlov, Alexander Bagaev, Maria V Revuelta, Jude M Phillip, Maria Teresa Cacciapuoti, Zoya Antysheva, Viktor Svekolkin, Ekaterina Tikhonova, Natalia Miheecheva, Natalia Kuzkina,[...]. Cancer Discov 2021
49
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.